These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11891606)

  • 21. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis.
    Psathakis K; Mermigkis D; Papatheodorou G; Loukides S; Panagou P; Polychronopoulos V; Siafakas NM; Bouros D
    Eur J Clin Invest; 2006 May; 36(5):362-7. PubMed ID: 16634841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes of the activities of ET-1 in the serum and BALF of ILD patients and their clinical significance].
    Li Z; Xia S; Hou X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jul; 22(7):411-3. PubMed ID: 11775813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.
    Vizza CD; Letizia C; Badagliacca R; Sciomer S; Poscia R; Della Rocca G; Iacoboni C; Leonardo de L; Quattrucci S; Dario C; Luigi P; Fedele F
    Regul Pept; 2006 Sep; 136(1-3):85-91. PubMed ID: 16815566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrin-releasing peptide-like immunoreactive substance in bronchoalveolar lavage of idiopathic pulmonary fibrosis and sarcoidosis.
    Takeyama M; Nagai S; Kondo K; Morikawa N; Mio T; Satake N; Kitaichi M; Izumi T
    Eur Respir J; 1993 Mar; 6(3):418-24. PubMed ID: 8472833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease: prospective study of a cohort of 562 patients].
    Jara-Palomares L; Martín-Juan J; Gómez-Izquierdo L; Cayuela-Domínguez A; Rodríguez-Becerra E; Rodríguez-Panadero F
    Arch Bronconeumol; 2009 Mar; 45(3):111-7. PubMed ID: 19286112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.
    Shinoda H; Tasaka S; Fujishima S; Yamasawa W; Miyamoto K; Nakano Y; Kamata H; Hasegawa N; Ishizaka A
    Respiration; 2009; 78(3):285-92. PubMed ID: 19270434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of interleukin-13 in the serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis].
    Xiao L; Li ZH; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Nov; 26(11):686-8. PubMed ID: 14703444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
    Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
    Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of tryptase in bronchoalveolar lavage fluid from patients with sarcoidosis.
    Eklund A; van Hage-Hamsten M; Sköld CM; Johansson SG
    Sarcoidosis; 1993 Mar; 10(1):12-7. PubMed ID: 8134709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bronchoalveolar lavage fluid analysis in rheumatoid arthritis].
    Okuda Y; Takasugi K; Kurata N; Takahara J
    Ryumachi; 1993 Aug; 33(4):302-9. PubMed ID: 8235911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.
    Kowal-Bielecka O; Kowal K; Distler O; Rojewska J; Bodzenta-Lukaszyk A; Michel BA; Gay RE; Gay S; Sierakowski S
    Arthritis Rheum; 2005 Dec; 52(12):3783-91. PubMed ID: 16320329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNFalpha, interleukin-10 and interleukin-18 expression in cells of the bronchoalveolar lavage in patients with pulmonary complications following bone marrow or peripheral stem cell transplantation: a preliminary study.
    Hauber HP; Mikkilä A; Erich JM; Kröger N; Meyer A; Schoder V; Zander AR; Pforte A
    Bone Marrow Transplant; 2002 Oct; 30(8):485-90. PubMed ID: 12379886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
    Rottoli P; Magi B; Cianti R; Bargagli E; Vagaggini C; Nikiforakis N; Pallini V; Bini L
    Proteomics; 2005 Jul; 5(10):2612-8. PubMed ID: 15924291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma.
    Trakada G; Tsourapis S; Marangos M; Spiropoulos K
    Respir Med; 2000 Oct; 94(10):992-6. PubMed ID: 11059954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio].
    Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
    Przegl Lek; 1999; 56(2):144-7. PubMed ID: 10375948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
    Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
    Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro.
    Cambrey AD; Harrison NK; Dawes KE; Southcott AM; Black CM; du Bois RM; Laurent GJ; McAnulty RJ
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):439-45. PubMed ID: 7917311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases.
    Zissel G; Bäumer I; Schlaak M; Müller-Quernheim J
    Eur Cytokine Netw; 2000 Mar; 11(1):105-12. PubMed ID: 10705307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
    Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
    Bargagli E; Olivieri C; Nikiforakis N; Cintorino M; Magi B; Perari MG; Vagaggini C; Spina D; Prasse A; Rottoli P
    Respir Physiol Neurobiol; 2009 Jul; 167(3):261-7. PubMed ID: 19464392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.